Wednesday, July 8, 2026

pharma · Hypercholesterolemia · Hyperlipidemia · ESPR

Esperion Therapeutics

News and analysis for Esperion Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Ann Arbor, US HQ
5 Employees
Public company Type
ESPR · NYSE Ticker
Company details
Status
Public
HQ
Ann Arbor, US
Employees
5
Programs
15
Drugs
9
Patents
55
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Esperion Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Esperion Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Esperion Therapeutics yet.

Back to company overview →